Brain Cancer Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

News. Good morning, thank you for joining us on this tuesday morning, december 4th, i am pam cook. Lets check weather and traffic, steve is right there, should we leave the house with an umbrella . Yes. This is a much weaker system, so lets make sure we know that first and foremost. It is mainly a cloudy day, we have to wait for the rain to get here and that will not be anything compared to what we had over the weekend and we will talk more about those totals, here is tara. We are looking at highway 4 and traffic is moving nicely through orinda. This is the oakland coliseum, 880, no delays to ...

BeiGene Releases Report and Launches CancerandMentalHealth.com in Conjunction with World Cancer Day to Help Patients and Caregivers Overcome Barriers to Access BeiGene (NASDAQ: BGNE; HKEX: 06160;

BeiGene Releases Report and Launches CancerandMentalHealth.com in Conjunction with World Cancer Day to Help Patients and Caregivers Overcome Barriers to AccessBASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$BGNE #BeiGene--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology com...

/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...

Share this article Share this article DALLAS, Dec. 17, 2020 /PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR ® artificial intelligence ("A.I.") platform to transform cancer drug development and identify patients who will benefit from its targeted oncology therapeutics, today announced a collaboration and research agreement with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Kennedy Krieger Institute. The collaboration will focus on the further development of Lantern's LP-184 in glioblastoma multiforme (GBM). Based ...